Funder: Pediatric Cancer Research Foundation
Due Dates (Anticipated): April 2027 (LOI) | July 2027 (Full proposal)
Funding Amounts: Emerging Investigator: up to $75,000 for one year; prior-cycle Translational and Legacy awards: up to $100,000–$150,000 annually for two to three years
Summary: PCRF funds pediatric cancer research advancing promising treatments, equitable care, and survivorship and mental health outcomes.
Key Information: PIs must work at a U.S. nonprofit institution affiliated with a hospital; full proposals require an approved LOI.
The Pediatric Cancer Research Foundation (PCRF) supports childhood cancer research aimed at bringing promising treatments to children and overcoming obstacles in their care. Working directly with doctors, researchers, and nurses, the foundation prioritizes Powering Research, Equitable Care, and Survivorship & Mental Health. Its interests include more effective therapies with fewer short- and long-term side effects, AI and advanced technologies, clinical trials, and research addressing disparities in care.
PCRF’s 2026 solicitation was limited to Emerging Investigator Fellowship Grants supporting postdoctoral fellowships and clinical investigator training. The foundation plans to reopen its full grant cycle in 2027, including Translational Research Grants, Legacy Researcher Grants, and additional opportunities. Multi-institutional, interdisciplinary collaborations, consortia, and industry partnerships are strongly encouraged and reviewed favorably.